JP Morgan Initiates Coverage On Hims & Hers Health with Overweight Rating, Announces Price Target of $35

Benzinga Newsdesk www.benzinga.com Neutral 67.8%

Neg 0% Neu 67.8% Pos 0%

JP Morgan analyst Cory Carpenter initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Overweight rating and announces Price Target of $35.